ENSPRYNG® (satralizumab) Pregnancy Registry
Do you or someone you care for have neuromyelitis optica spectrum disorder (NMOSD)? Are you or have they been pregnant? Have you or they taken ENSPRYNG® (satralizumab) 6 months before getting pregnant or any time during the pregnancy? If so, you/they may be able to take part in this registry. Get in touch with the coordinating center to learn more.
Call to learn moreAbout pregnancy and NMOSD
The effects of a particular treatment on pregnancy outcomes are often unknown because pregnant women are rarely included in the clinical research studies that evaluate potential new treatments. Pregnancy registries aim to collect information that could support women and their healthcare providers in making more informed decisions about using a particular treatment during pregnancy and breastfeeding in the future.
What is the ENSPRYNG Pregnancy Registry?
The ENSPRYNG Pregnancy Registry is for women with NMOSD who are or have been pregnant while taking ENSPRYNG® (satralizumab). This is defined as taking satralizumab within the 6 months before getting pregnant or at any time during pregnancy. A pregnancy registry is an observational study that gathers information about participants without providing any additional treatments or medications.
The purpose of this pregnancy registry is to learn more about the health of pregnant women who received satralizumab and the health of their babies. During their participation in the registry, participants will be asked to share information about their health, their pregnancy and breastfeeding (if applicable), and their baby’s health. Participants will not be required to take any additional or investigational medications other than the medications they already take as part of their routine care.
The ENSPRYNG Pregnancy Registry aims to gather information about how pregnancies and babies may or may not be affected. The study information may help pregnant women who take satralizumab in the future.
Have questions?
Have questions?
Visit the FAQs section for the answers to common questions that you may have about the ENSPRYNG Pregnancy Registry.
Am I eligible?
You may be able to take part in this registry if you have NMOSD and you:
and
Call now
How do I participate?
Call the coordinating center at 1 (833) 277-9338
Call nowContact the coordinating center by email:
NMOSDPregnancy@jefferson.edu
For the latest important safety information, please refer to the full Prescribing Information and Patient Information. This is not intended to replace discussions with your healthcare provider.